NCT05383274 - Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 14, 2022

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2026

Conditions

Urethral Stricture

Interventions

COMBINATION_PRODUCT

Optilume Urethral DCB

The Optilume Drug Coated Balloon (DCB) is a guidewire compatible catheter with a tapered atraumatic tip. The distal end of the catheter has an inflatable balloon coated with a proprietary coating containing the drug paclitaxel that facilitates the drug's transfer to the urethral wall upon inflation.

Trial Locations (9)

14225

RECRUITING

Western New York, Cheektowaga

21076

COMPLETED

Chesapeake, Hanover

32806

RECRUITING

Orlando Health, Orlando

33615

RECRUITING

Florida Urology, Tampa

71106

COMPLETED

Regional Urology, Shreveport

72211

RECRUITING

Arkansas Urology, Little Rock

75231

RECRUITING

Urology Clinics of North Texas, Dallas

89144

RECRUITING

Freedman Urology, Las Vegas

07041

COMPLETED

New Jersey Urolgy, Millburn